细菌驱动炎症与突变BRAF表达协同促进小鼠结肠肿瘤发生且对免疫检查点治疗敏感
该研究在小鼠Wnt驱动多发肠肿瘤模型(MinApcΔ716/+)基础上引入BRAF V600E突变,并定植产肠毒素脆弱拟杆菌(ETBF),发现BLM小鼠中结肠中部出现肿瘤,其组织学、CpG岛DNA高甲基化和免疫特征与人BRAF V600E肿瘤相似。与Min ETBF肿瘤相比,BLM ETBF肿瘤有CD8+ T细胞浸润、表达IFNγ特征,并对anti-PD-L1治疗敏感。
要点
- 产肠毒素脆弱拟杆菌定植联合BRAF V600E突变可协同促进小鼠结肠中部肿瘤发生。
- BLM ETBF肿瘤模拟人BRAF突变肿瘤的组织学、CpG岛高甲基化和免疫特征。
- BLM ETBF肿瘤富集CD8+ T细胞和IFNγ特征,对anti-PD-L1治疗敏感。
核心结论
- 宿主遗传与微生物群相互作用在结直肠癌发病及免疫治疗敏感性中起关键作用。
- BRAF V600E突变与产肠毒素脆弱拟杆菌定植协同驱动小鼠结肠肿瘤发生,并形成对免疫检查点阻断敏感的IFNγ优势免疫微环境。
研究设计与样本
- 研究使用Wnt驱动的MinApcΔ716/+小鼠模型,并在其基础上引入BRAF V600E突变(BLM小鼠),结合产肠毒素脆弱拟杆菌(ETBF)定植。
- 比较了BLM ETBF小鼠肿瘤与Min ETBF小鼠肿瘤的特征,并评估了anti-PD-L1治疗敏感性。
主要发现
- 在ETBF定植的BLM小鼠中,肿瘤出现在结肠中部一个 distinct locus。
- BLM ETBF肿瘤与人BRAF V600E肿瘤在组织学、CpG岛DNA高甲基化和免疫特征上具有相似性。
- 与Min ETBF肿瘤相比,BLM ETBF肿瘤有CD8+ T细胞浸润,表达IFNγ特征,并对anti-PD-L1治疗敏感。
临床怎么用
- 对于BRAF V600E突变结直肠癌,尤其存在产肠毒素脆弱拟杆菌相关炎症微环境时,可考虑免疫检查点治疗(如anti-PD-L1)的潜在获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colorectal cancer is multifaceted, with subtypes defined by genetic, histologic, and immunologic features that are potentially influenced by inflammation, mutagens, and/or microbiota. Colorectal cancers with activating mutations in BRAF are associated with distinct clinical characteristics, although the pathogenesis is not well understood. The Wnt-driven multiple intestinal neoplasia (MinApcΔ716/+) enterotoxigenic Bacteroides fragilis (ETBF) murine model is characterized by IL17-dependent, distal colon adenomas. Herein, we report that the addition of the BRAF V600E mutation to this model results in the emergence of a distinct locus of midcolon tumors. In ETBF-colonized BRAF V600E Lgr5 CreMin (BLM) mice, tumors have similarities to human BRAF V600E tumors, including histology, CpG island DNA hypermethylation, and immune signatures. In comparison to Min ETBF tumors, BLM ETBF tumors are infiltrated by CD8+ T cells, express IFNγ signatures, and are sensitive to anti-PD-L1 treatment. These results provide direct evidence for critical roles of host genetic and microbiota interactions in colorectal cancer pathogenesis and sensitivity to immunotherapy. SIGNIFICANCE: Colorectal cancers with BRAF mutations have distinct characteristics. We present evidence of specific colorectal cancer gene-microbial interactions in which colonization with toxigenic bacteria drives tumorigenesis in BRAF V600E Lgr5 CreMin mice, wherein tumors phenocopy aspects of human BRAF-mutated tumors and have a distinct IFNγ-dominant immune microenvironment uniquely responsive to immune checkpoint blockade.This article is highlighted in the In This Issue feature, p. 1601.
引用
- DeStefano Shields CE, White JR, Chung L, et al. Bacterial-Driven Inflammation and Mutant BRAF Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint Therapy. Cancer Discov. 2021. PMID: 33632774. doi:10.1158/2159-8290.CD-20-0770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。